Cargando…

Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L

BACKGROUND: In clinical studies, the EQ-5D-5L is often employed with disease-specific health-related quality of life instruments. The questions in the former are more general than the latter; however, it is known that responses to general questions can be influenced by preceding specific questions....

Descripción completa

Detalles Bibliográficos
Autores principales: Izumi, Shoki, Hagiwara, Yasuhiro, Matsuyama, Yutaka, Shiroiwa, Takeru, Taira, Naruto, Kawahara, Takuya, Konomura, Keiko, Noto, Shinichi, Fukuda, Takashi, Shimozuma, Kojiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843919/
https://www.ncbi.nlm.nih.gov/pubmed/36650539
http://dx.doi.org/10.1186/s12955-022-02085-8
_version_ 1784870505095888896
author Izumi, Shoki
Hagiwara, Yasuhiro
Matsuyama, Yutaka
Shiroiwa, Takeru
Taira, Naruto
Kawahara, Takuya
Konomura, Keiko
Noto, Shinichi
Fukuda, Takashi
Shimozuma, Kojiro
author_facet Izumi, Shoki
Hagiwara, Yasuhiro
Matsuyama, Yutaka
Shiroiwa, Takeru
Taira, Naruto
Kawahara, Takuya
Konomura, Keiko
Noto, Shinichi
Fukuda, Takashi
Shimozuma, Kojiro
author_sort Izumi, Shoki
collection PubMed
description BACKGROUND: In clinical studies, the EQ-5D-5L is often employed with disease-specific health-related quality of life instruments. The questions in the former are more general than the latter; however, it is known that responses to general questions can be influenced by preceding specific questions. Thus, the responses to the EQ-5D-5L have the possibility of being influenced by the preceding disease-specific health-related quality of life instruments. This may lead to bias in the cost-effectiveness analysis results. Therefore, this study aimed to evaluate the impact of the preceding cancer-specific health-related quality of life instruments on the EQ-5D-5L responses. METHODS: We prepared questionnaire booklets containing the EQ-5D-5L, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, and the Functional Assessment of Cancer Therapy General with different orders. Using a quasi-randomized design, they were distributed to the patients undergoing drug therapy for advanced cancer, who were classified into three groups: Groups 1, 2, and 3 (the EQ-5D-5L placed first, second, and last, respectively). We compared the EQ-5D-5L index and the missingness of EQ-5D-5L among the groups. RESULTS: The mean EQ-5D-5L index was 0.796, 0.760, and 0.789 for groups 1 (n = 300), 2 (n = 306), and 3 (n = 331), respectively. The difference between Groups 2 and 1 was − 0.036 (95% CI − 0.065 to − 0.007; p = 0.015). The proportion of patients with an incomplete EQ-5D-5L was 0.11, 0.11, and 0.05 for Groups 1, 2, and 3, respectively. The difference of the proportions between group 3 and 1 and between 3 and 2 was − 0.06 (95% CI − 0.10 to − 0.02; p = 0.003) and − 0.06 (95% CI − 0.10 to − 0.02; p = 0.003), respectively. CONCLUSIONS: Although the EQ-5D-5L index differed according to the instrument orders, the difference size would not be considerably larger than the minimally important difference. The patients tended to complete the EQ-5D-5L when they were placed at the end of the questionnaire. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12955-022-02085-8.
format Online
Article
Text
id pubmed-9843919
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98439192023-01-18 Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L Izumi, Shoki Hagiwara, Yasuhiro Matsuyama, Yutaka Shiroiwa, Takeru Taira, Naruto Kawahara, Takuya Konomura, Keiko Noto, Shinichi Fukuda, Takashi Shimozuma, Kojiro Health Qual Life Outcomes Research BACKGROUND: In clinical studies, the EQ-5D-5L is often employed with disease-specific health-related quality of life instruments. The questions in the former are more general than the latter; however, it is known that responses to general questions can be influenced by preceding specific questions. Thus, the responses to the EQ-5D-5L have the possibility of being influenced by the preceding disease-specific health-related quality of life instruments. This may lead to bias in the cost-effectiveness analysis results. Therefore, this study aimed to evaluate the impact of the preceding cancer-specific health-related quality of life instruments on the EQ-5D-5L responses. METHODS: We prepared questionnaire booklets containing the EQ-5D-5L, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, and the Functional Assessment of Cancer Therapy General with different orders. Using a quasi-randomized design, they were distributed to the patients undergoing drug therapy for advanced cancer, who were classified into three groups: Groups 1, 2, and 3 (the EQ-5D-5L placed first, second, and last, respectively). We compared the EQ-5D-5L index and the missingness of EQ-5D-5L among the groups. RESULTS: The mean EQ-5D-5L index was 0.796, 0.760, and 0.789 for groups 1 (n = 300), 2 (n = 306), and 3 (n = 331), respectively. The difference between Groups 2 and 1 was − 0.036 (95% CI − 0.065 to − 0.007; p = 0.015). The proportion of patients with an incomplete EQ-5D-5L was 0.11, 0.11, and 0.05 for Groups 1, 2, and 3, respectively. The difference of the proportions between group 3 and 1 and between 3 and 2 was − 0.06 (95% CI − 0.10 to − 0.02; p = 0.003) and − 0.06 (95% CI − 0.10 to − 0.02; p = 0.003), respectively. CONCLUSIONS: Although the EQ-5D-5L index differed according to the instrument orders, the difference size would not be considerably larger than the minimally important difference. The patients tended to complete the EQ-5D-5L when they were placed at the end of the questionnaire. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12955-022-02085-8. BioMed Central 2023-01-17 /pmc/articles/PMC9843919/ /pubmed/36650539 http://dx.doi.org/10.1186/s12955-022-02085-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Izumi, Shoki
Hagiwara, Yasuhiro
Matsuyama, Yutaka
Shiroiwa, Takeru
Taira, Naruto
Kawahara, Takuya
Konomura, Keiko
Noto, Shinichi
Fukuda, Takashi
Shimozuma, Kojiro
Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L
title Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L
title_full Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L
title_fullStr Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L
title_full_unstemmed Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L
title_short Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L
title_sort impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent eq-5d-5l
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843919/
https://www.ncbi.nlm.nih.gov/pubmed/36650539
http://dx.doi.org/10.1186/s12955-022-02085-8
work_keys_str_mv AT izumishoki impactsoftheprecedingcancerspecifichealthrelatedqualityoflifeinstrumentsontheresponsestothesubsequenteq5d5l
AT hagiwarayasuhiro impactsoftheprecedingcancerspecifichealthrelatedqualityoflifeinstrumentsontheresponsestothesubsequenteq5d5l
AT matsuyamayutaka impactsoftheprecedingcancerspecifichealthrelatedqualityoflifeinstrumentsontheresponsestothesubsequenteq5d5l
AT shiroiwatakeru impactsoftheprecedingcancerspecifichealthrelatedqualityoflifeinstrumentsontheresponsestothesubsequenteq5d5l
AT tairanaruto impactsoftheprecedingcancerspecifichealthrelatedqualityoflifeinstrumentsontheresponsestothesubsequenteq5d5l
AT kawaharatakuya impactsoftheprecedingcancerspecifichealthrelatedqualityoflifeinstrumentsontheresponsestothesubsequenteq5d5l
AT konomurakeiko impactsoftheprecedingcancerspecifichealthrelatedqualityoflifeinstrumentsontheresponsestothesubsequenteq5d5l
AT notoshinichi impactsoftheprecedingcancerspecifichealthrelatedqualityoflifeinstrumentsontheresponsestothesubsequenteq5d5l
AT fukudatakashi impactsoftheprecedingcancerspecifichealthrelatedqualityoflifeinstrumentsontheresponsestothesubsequenteq5d5l
AT shimozumakojiro impactsoftheprecedingcancerspecifichealthrelatedqualityoflifeinstrumentsontheresponsestothesubsequenteq5d5l